Today: 19 May 2026
British American Tobacco share price dips as buyback keeps ticking and Feb 12 results loom
6 February 2026
1 min read

British American Tobacco share price dips as buyback keeps ticking and Feb 12 results loom

London, February 6, 2026, 08:02 GMT — Regular session

  • BAT shares slipped 0.2% early Friday, following a 1.4% gain in the previous session
  • The company announced another tranche of share buybacks, confirming those shares will be cancelled.
  • Investors are eyeing the February 12 results to gauge the 2026 outlook and potential cash returns

British American Tobacco shares edged down 0.2% to 4,548 pence in early London deals on Friday, following a 1.4% gain to 4,555 pence the day before. The stock kicked off at 4,560 pence, oscillating within a tight band of 4,546 to 4,567 pence.

These shifts carry weight as BAT approaches its full-year results, a key test for its pricing power, non-cigarette growth, and shareholder returns. The company will release its 2025 preliminary results on Feb. 12, followed by a webcast that same morning with CEO Tadeu Marroco at the helm.

On Friday, a stock exchange filing revealed BAT repurchased 121,668 shares from UBS on Feb. 5, paying a volume-weighted average price of 4,535.6560 pence each. The firm plans to cancel these shares, trimming its total share count.

On Feb. 4, BAT bought back 136,167 shares at a volume-weighted average price of 4,541.4024 pence, continuing the same programme.

Income remains a key factor in the trade. BAT handed out its most recent quarterly dividend of 60.06 pence per share on Feb. 4, per data from Hargreaves Lansdown.

Back in December, BAT flagged that its 2026 results might just hit the bottom end of its mid-term targets, hit by tougher regulation and fierce competition in the U.S. vape sector. “I’m trying to be cautious for 2026,” Marroco said then. Rae Maile at Panmure Liberum described the update as “perhaps not quite what the share price needed.” Reuters

The downside scenario is straightforward: if the Feb. 12 figures reveal slowing momentum in vaping and oral nicotine, or a heavier blow from regulatory shifts and enforcement, investors might overlook the buyback and focus on the outlook instead.

Elsewhere in UK tobacco, Imperial Brands dipped roughly 0.5% in early trading, highlighting a more subdued mood in that sector.

Stock Market Today

  • Western Digital Leverages Post-Quantum Cryptography to Enhance AI Data Security
    May 19, 2026, 9:57 AM EDT. Western Digital Corporation (WDC) integrates post-quantum cryptography (PQC) into its Ultrastar UltraSMR hard drives to address future AI data security risks. The drives, undergoing qualification with hyperscale customers, embed PQC directly into storage firmware, enhancing protection against quantum-era threats by ensuring firmware integrity and secure key management. Using NIST-aligned ML-DSA-87 and RSA-3072 algorithms, WDC advances device-level trust with dual-signing strategies. This positions WDC ahead in quantum-resistant enterprise storage security. Competitor Seagate Technology (STX) continues focusing on durable, cost-efficient storage solutions amid rising AI data demands, while WDC's split into SanDisk aims to capitalize further on AI-driven markets.

Latest articles

Bakkt Up Early After Director Buys $4.85M in Shares

Bakkt Up Early After Director Buys $4.85M in Shares

19 May 2026
Bakkt shares jumped 14.2% to $9.96 in pre-market trading Tuesday after a filing showed director Michael Alfred’s vehicle bought $4.85 million in stock. SEC documents said Alfred acquired 585,000 shares last week via Alpine Fox LP. CEO Akshay Naheta exercised options for 33,557 shares at $10 each. Bakkt recently reported Q1 revenue of $243.6 million, down sharply from a year earlier.
Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update

19 May 2026
Relay Therapeutics shares jumped 11.3% to $13.47 in premarket trading Tuesday after reporting a 60% volumetric response rate in 20 evaluable patients from its Phase 2 trial of zovegalisib for vascular anomalies. The company said 95% of patients saw some lesion reduction at 12 weeks. No patients discontinued due to adverse events. The regular Nasdaq session was set to open at 9:30 a.m. ET.

Popular

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

18 May 2026
Roblox shares rose 9.6% to $46.98 on Monday, bucking declines in the broader tech sector. The jump followed a month-long selloff tied to new child-safety measures, which the company says have reduced user communication and slowed new sign-ups. Roblox cut its 2026 bookings outlook on April 30, but first-quarter revenue and daily active users both rose over 35%. Analysts cited competition from Fortnite and the upcoming Grand Theft Auto VI.
P&G stock price climbs in late trade as investors rotate to defensives — and an insider sale hits the tape
Previous Story

P&G stock price climbs in late trade as investors rotate to defensives — and an insider sale hits the tape

Compass Group share price slips again as AI fears linger after Q1 update
Next Story

Compass Group share price slips again as AI fears linger after Q1 update

Go toTop